Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis

BACKGROUND: Budesonide foam, a rectally administered, second-generation corticosteroid with extensive hepatic first-pass metabolism, is efficacious for the treatment of mild-to-moderate ulcerative proctitis and ulcerative proctosigmoiditis. AIM: The aim of this study was to comprehensively assess th...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Dig Dis Sci
Glavni autori: Rubin, David T., Sandborn, William J., Bosworth, Brian, Zakko, Salam, Gordon, Glenn L., Sale, Mark E., Rolleri, Robert L., Golden, Pamela L., Barrett, Andrew C., Bortey, Enoch, Forbes, William P.
Format: Artigo
Jezik:Inglês
Izdano: Springer US 2015
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4621699/
https://ncbi.nlm.nih.gov/pubmed/26386854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-015-3868-5
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items